ORLANDO, FLORIDA / ACCESS Newswire / July 25, 2025 / RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV, this Saturday, July 26, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
Access the interview in its entirety at: https://www.redchip.com/assets/access/ltrn_access
In an exclusive interview, Panna Sharma, CEO of Lantern Pharma, appears on the RedChip Small Stocks Big Money show on Bloomberg TV to discuss how Lantern is redefining oncology drug development through its proprietary AI platform, RADR®. Sharma highlights Lantern's clinical-stage programs (LP-300, LP-184, and LP-284) which address high-need indications such as NSCLC in never-smokers, DDR-deficient solid tumors, and aggressive lymphomas. He also shares how Lantern's capital-efficient AI-driven model, which has enabled 12 oncology programs in just two years at a fraction of traditional development costs, is driving rapid value creation. With multiple upcoming clinical readouts, an expanding AI-driven pipeline, and over 100 issued and pending patents, Lantern is positioned as a next-generation biotech innovator at the intersection of artificial intelligence and precision oncology.
LTRN is a client of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About Lantern Pharma
Lantern Pharma (NASDAQ:LTRN) is an AI-driven biotechnology company focused on accelerating and optimizing the discovery, development, and commercialization of cancer therapies. Its RADR® platform leverages artificial intelligence and machine learning to uncover novel therapeutic opportunities, accelerate drug development, and improve patient outcomes.
Please find more information at:
Website: www.lanternpharma.com
LinkedIn: https://www.linkedin.com/company/lanternpharma/
X: @lanternpharma
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com
--END--
SOURCE: RedChip Companies, Inc. (Media Suite)
View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/lantern-pharma-interview-to-air-on-the-redchip-small-stocks-big-1052899
